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A novel effective procedure for the purification of cathepsin D inhibitor from potatoes (PDI) was developed. The amino 
acid sequence of PDI was determined by analysis of the cyanogen bromide digest and of the limited tryptic and chymo- 
tryptic digests of the protein. The inhibitor is a single polypeptide chain protein consisting of 188 residues with a simple 
sugar moiety attached to Asn-19. The tentative disulfide pairings are also suggested. The sequence data clearly indicate 
that PDI is homologous with the soybean trypsin inhibitor (STI) (Kunitz) family. The active center of PDI for trypsin 
inhibition was identified as Pro-Val-Arg-Phe in analogy to STI. 
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1. INTRODUCTION 
The interest in naturally occurring inhibitors of 
proteolytic enzymes has been increasing mainly 
because of their possible use as therapeutic agents. 
Very little is known so far about inhibitors of 
aspartic proteinases of protein character. The in- 
hibitor isolated from the roundworm Ascaris lum- 
bricoides is a potent inhibitor of pepsin, gastricsin 
and cathepsin E [ 1,2]. Intact activation (propart) 
peptides represent another type of such inhibitors 
[3]. Inhibitor IAs of proteinase A from yeast 
displays a surprising singularity of inhibition with 
respect o the other aspartic proteinases [4]. So far 
no cathepsin D inhibitor of tissue origin has been 
described in spite of the fact that this major 
lysosomal aspartic proteinase [5] plays an impor- 
tant role in many physiological or pathophysiolog- 
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ical processes such as neurodegenerative changes 
[6]. The only well characterized cathepsin D in- 
hibitor of protein character is the inhibitor from 
potato tubers (PDI) [7]. PDI inhibits, however, 
besides cathepsin D also trypsin. A preliminary 
chemical characterization of PDI has shown that 
PDI is a type of trypsin inhibitor not discovered so 
far in potatoes [8]. 
The aim of the present study has been to deter- 
mine the structure characteristics of PDI and thus 
to provide a basis for the investigation of its rela- 
tionship with trypsin inhibitors in general and for 
future studies on the mechanism of cathepsin D in- 
hibition from the molecular viewpoint. Structure 
studies of the same inhibitor have reached an ad- 
vanced stage also in Professor Turk’s group at the 
J. Stefan Institute in Ljubljana [9]. 
2. MATERIALS AND METHODS 
Potatoes used for isolation of PDI were of commercial 
origin. Cathepsin D used for the PDI assay [7] was prepared 
from bovine spleen essentially according to [lo] using affinity 
chromatography on pepstatin-Sepharose as a last step. The 
FPLC system was from Pharmacia AB, Sweden. Trypsin- and 
cathepsin D-Sepharose were prepared and trypsin inhibition 
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assayed as described elsewhere [ll]. Purification of PDI was 
performed initially according to [7]; after gel filtration the ion- 
exchange chromatography step on a Mono Q column 
equilibrated in 0.1 M ethanolamine-HCI buffer, pH 10.0, was 
included (fig.1). The homogeneity of PDI and of its large 
fragments was examined by SDS-PAGE in 12.5% gels as in 
[12]. The cleavage of carboxymethylated PDI [13] by CNBr, 
after preceding reduction of methionine sulfoxide present in the 
protein by mercaptoacetic acid [14], was carried out as in [15]. 
The CNBr fragments after citraconylation [la] were resolved on 
Sephadex G-100 (Pharmacia) in 6 M guanidinium chloride. The 
desalting was carried out on Sephadex G-25 in 0.5% NHdHCOs 
and both CNBr fragments were further cleaved by trypsin 
(80: 1, w/w; 2 h; 37°C). The resulting subfragments (CB-LT) 
were separated by gel chromatography on Sephadex G-50 in 
0.5% NHbHCOs and then purified by HPLC (Beckman-Altex 
Model 420 Liquid Chromatograph). An Ultrapore RPSC col- 
umn (Beckman, USA) in 0.1% ammonium acetate buffer, pH 
6.5, and a gradient of acetonitrile were used. Alternatively the 
carboxymethylated protein was citraconylated and digested 
with trypsin as in [17]. The resulting fragments (LT) were 
separated by gel chromatography on Sephadex G-50 in 0.5% 
NHdHCOs, then decitraconylated as described elsewhere 1161 
and purified by HPLC (see above) whenever necessary. The 
subsequent cleavage of the LT fragments by trypsin was carried 
out as described for the CB-LT fragments. The resulting pep- 
tides (LT-Tr) were purified by RP HPLC. For the determina- 
tion of some overlaps, the carboxymethylated protein was also 
digested with chymotrypsin in 0.5% NHdHCOp at a substrate 
to enzyme ratio of 50: 1 (w/w) for 2 h at 37°C. The peptides 
were separated by HPLC on a Vydac 218TP54 column (Separa- 
tions Group, USA). Amino sugars, neutral sugars and fucose 
were quantified as described elsewhere [17]. The amino acid 
analyses were carried out using a Durrum D-500 amino acid 
analyzer. The amino acid sequences were determined on an Ap- 
plied Biosystems model 470A protein sequencer using the pro- 
gram provided by the instrument manufacturer. The 
phenylthiohydantoins were identified by HPLC as in [18]. The 
carboxypeptidase A digestion of carboxymethylated PDI in 
0.25% SDS and 0.1 M N-methylmorpholine, pH 8.5, was per- 
formed according to [19]. 
3. RESULTS AND DISCUSSION 
The first aim of this study was to simplify the 
process of PDI purification in order to obtain 
higher yields than by the original procedure [7]. 
Chromatography on a Mono Q column (fig. 1) was 
found to be sufficient for the isolation of pure PDI 
by a one step procedure. A large number of other, 
more basic trypsin inhibitors were separated con- 
comitantly. PDI was eluted from the column as the 
only symmetrical peak showing both anticathepsin 
D and antitrypsin activity. To provide evidence 
that these two activities cannot be separated we 
repeated the experiments of Keilova [l l] with af- 
finity chromatography on cathepsin D- and 
0.3 
NaCl 
[Ml 
0.0 
Fig.1. Chromatography of crude PDI on Mono Q column 
(4.6 x 75 mm). A solution of 0.1 M ethanolamine-HCl, pH 
10.0, was used as starting buffer. The lyophilisate (10 mg, after 
gel filtration) dissolved in 2 ml of starting buffer was applied 
and eluted at a flow rate of 1 ml/min by a 0.0-0.3 M gradient 
of NaCl. A2s0 was measured continuously, 1 ml fractions were 
collected and 100 ~1 aliquots were assayed for anticatheptic (0) 
[7] and antitryptic (0) [ll] activity. 
trypsin-Sepharose columns. In both cases the pro- 
tein peak corresponding to PDI purified by affini- 
ty chromatography coincided with the peak of 
both anticathepsin D and antitrypsin activity. The 
preparation obtained by chromatography on the 
Mono Q column was therefore considered 
homogeneous. Its M, value according to SDS- 
PAGE is 22000. The following amino acid analysis 
of PDI, i.e. Asp 25.5; Thr 8.1; Ser 12.7; Glu 11.5; 
Pro 15.0; Gly 17.9; Ala 7.0; Cys 5.8; Val 15.0; Met 
0.9; Be 11.5; Leu 20.5; Tyr 8.3; Phe 11.2; Lys 9.2; 
Arg 8.1; Trp 1.0 is in good agreement both with 
the M, value determined by SDS-PAGE and with 
the sequence data (the calculated M, is 20582 
without sugars). PDI is a glycoprotein containing 
2 GlcNHz residues, 4-5 neutral sugar residues and 
0.8 fucose residues. The carbohydrate moiety of 
PDI attached to Asn-19 is thus a simple type, Asn- 
linked oligosaccharide [20]. The other site of post- 
translational modification is the only methionine 
residue of PDI. Alkaline hydrolysis of PDI [14] 
provided unambiguous evidence of the presence of 
methionine sulfoxide to methionine of 1: 1; this 
finding explains incomplete cleavage at the 
methionine residue by CNBr. The fact that the 
conversion of MeSO to Met is incomplete even 
after exhaustive reduction suggests that the 
sulfonium salt of Met rather than MeSO alone is 
present. 
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We were able to sequence the intact carbox- 
ymethylated protein up to the 58th residue. To ob- 
tain additional information, limited tryptic 
digestion and CNBr cleavage of the carbox- 
ymethylated PDI were carried out in parallel ex- 
periments. All the bonds were cleaved as expected 
with the exception of that involving Arg-154. The 
failure to obtain cleavage at this site (fig.2) can be 
accounted for by the fact that Arg-154 is surround- 
ed by three acid residues (CmCys-153, Asp-155 
and -156). Both CNBr fragments were further sub- 
jected to limited tryptic digestion to obtain infor- 
mation on the order of the LT fragments (fig.2). 
The LT fragments after decitraconylation were 
cleaved by trypsin. All these data, together with 
the knowledge of the peptides resulting from 
chymotryptic digestion of PDI, enabled us to 
derive the primary structure of PDI shown in fig.3. 
This structure is homologous to the structure of 
soybean trypsin inhibitor (STI) [21] and to that of 
the related winged bean trypsin inhibitor (WTI) 
[22]. From sequence homologies it was recently 
shown that the doubleheaded a-amylase/subtilisin 
inhibitor from barley [23] as well as the inhibitors 
of cysteine proteinases from potatoes [24] also 
belong to the same structural superfamily. This 
structural arrangement thus seems to be very 
widespread among different kinds of inhibitors. 
The homology of PDI and ST1 is more pronounc- 
ed in N- and C-terminal parts of the molecule but 
it is considerably lower in other parts. We used the 
first two half-cystines (Cys-48 and -93) forming a 
disulfide in ST1 as an ‘alignment marker’. The ac- 
tive site for trypsin inhibition should be 
represented by Arg-67 in analogy with STI. The in- 
variant Pro-65 residue in position P3 [25] also 
50 
seems to be important and our alignment was 
made to meet this criterion. The secondary struc- 
ture prediction by several methods and the 
resulting prediction [26] indicate the presence of 
only one helical region (res.76-82), which is in- 
serted in PDI in contrast to STI. From the ex- 
perimentally determined tertiary structure of ST1 
[27] there is no helical region in this inhibitor; this 
indicates a common core structure of PDI and 
STI. The high predicted content of &structures in 
PDI is also in accordance with the tertiary struc- 
ture of STI. Many insertions and deletions on the 
surface of the molecules compared had to be in- 
troduced, however, to obtain an appropriate align- 
ment (fig.3). 
ST1 has two disulfides of which the second 
forms a short loop [27] on the surface 
(Cys-142-Cys-153). PDI should contain three 
disulfides, the second and third lying in the region 
of the second ST1 disulfide; hence, the alignment 
of half-cystines in this part of, the molecule should 
be considered as only tentative (the pairing 
Cys-142-Cys-153 being a counterpart of the se- 
cond disulfide of STI). 
All these facts indicate that the structures of PDI 
and ST1 are not simply superimposable. It is of in- 
terest that the sequence Cys-Pro-Phe-Cys present 
in PDI (res.150-153) is homologous to the active 
center of glutaredoxin which plays a role in the 
reduction of ribonucleotides [28]. Recent literature 
has provided data on the multivalency of STI, at 
least as far as chymotrypsin binding is concerned 
[29]. There is no doubt that the homologous a- 
amylase/subtilisin inhibitor from barley is 
doubleheaded. PDI is both a trypsin and cathepsin 
D inhibitor. It is too early to speculate whether the 
100 150 
CB 
LT 
CB-LT 
LT-Tr 
Ch 
Fig.2. Summary of sequence data. Bars represent individual fragments, their length is proportional to their size. CB, cyanogen bromide 
fragments; LT, limited tryptic fragments; CB-LT, limited tryptic fragments prepared from CB fragments; LT-Tr, tryptic peptides 
prepared from LT fragments after decitraconylation; Ch, chymotryptic peptides. 
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10 + 20 30 
ESPLPKPVLDTNGKELNPNSSYRIISIGRG 
DFVLDNEGNPLENGGTYYILS-DIT 
EPLLDSEGELVRNGGTYYLLP-DRW 
40 50 
ALGGDVYLGKSPNSDAPCPDGVFRYN---- 
AFGG---IRAAPTGNERCPLTVVQSRNELD 
ALGGG-- IEAAATGTETCPLTVVRS----- 
60 * 70 80 
-SDVGPSGTPVRFIPLSGGIFEDQLLNIQF 
KGIGTIISSPYRIRFIAEGHP---LSLKFD 
-PNEVSVGEPLRISSQLRSGFIPDYSLVRI 
90 100 110 
N IA T VKLCVSY T- IWKVGNLNAYFRTMLLE 
SFAVIMLCVGIPTEWSVVEDLPEGPAVKIG 
GFANPPKCAPSP-WWTVVEDQPQQPSVKLS 
120 130 140 
TGGTIGQADSSYFKIVKLS---NFGYNLLY 
ENKDAM---DGWFRLERVSDDEFNNYKLVF 
ELKSTKF--DYLFKFEKVTS-KFSSYKLKY 
150 160 
CPITPPFLCPFCRDDNFCAKVGVVIQN--G 
CPQQAEDDK--CGD----- -1GISIDHDDG 
CAKRDT-----CKD----- -IGIYRDQK-G 
170 180 
KRRLALVNENPLDVLFQEV 
TRRLVVSKNKPLVVQFQKLDKESL 
YARLVVTDENPLVVIFKKVESS 
Fig.3. Alignment of amino acid sequence of potato cathepsin D inhibitor (PDI) with sequence of soybean trypsin inhibitor (STI) and 
winged bean trypsin inhibitor (WTI). The residues are numbered according to PDI. Identical residues are set in boldface type. 
Glycosylated Asn-19 is marked by a cross, the putative active site for trypsin inhibition (Arg-67) by an asterisk. 
active site for trypsin inhibition is also responsible 
for the cathepsin D inhibition or whether there is 
another binding site responsible for the inhibition 
of cathepsin D. A possible candidate could be the 
bond Lys-91-Leu-92 in the vicinity of the second 
half-cystine; in ST1 there is a Met-Leu bond at the 
corresponding site which is cleaved by subtilisin 
[301. 
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